Home > Result Summaries: Compounds > Human Papillomavirus Types 16 and 18 Vaccine > Result Summary for 111375

Result Summary for 111375

Result Summary

Protocol ID:	111375
Clinical Study ID:	111375
Official Title:	Follow-up study to evaluate the long-term immunogenicity and safety of a HPV vaccine (580299) in healthy female subjects
Phase:	phase 3
Study Indications or Diseases:	Human Papillomavirus (HPV)
Generic Name:	Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name:	Cervarix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Schwarz TF et al. Long-term immunogenicity and safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescent girls: results from a 5 year follow-up. Abstract presented at the 29th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). The Hague, The Netherlands, 7-11 June 2011. Schwarz TF et al. LONG-TERM IMMUNOGENICITY AND SAFETY OF THE HPV-16/18 AS04-ADJUVANTED VACCINE IN ADOLESCENT GIRLS AGED 10–14 YEARS: 6-YEAR FOLLOW-UP. Abstract presented at the 30th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Thessaloniki, Greece, 8–12 May, 2012.